1. Rogers HW, Weinstock MA, Feldman SR et al. Incidence estimate of nonmelanoma skin cancer (keratinocyte carcinomas) in the U.S. population, 2012. JAMA Dermatol 2015; 151: 1081-1086.
2.
Nehal KS, Bichakjian CK. Update on keratinocyte carcinomas. N Engl J Med 2018; 379: 363-374.
3.
Nagarajan P, Asgari MM, Green AC et al. Keratinocyte carcinomas: current concepts and future research priorities. Clin Cancer Res 2019; 25: 2379-2391.
4.
Chen JT, Kempton SJ, Rao VK. The economics of skin cancer: an analysis of medicare payment data. Plast Reconstr Surg Glob Open 2016; 4: e868.
5.
Kalaghchi B, Esmati E, Ghalehtaki R et al. High-dose-rate brachytherapy in treatment of non-melanoma skin cancer of head and neck region: preliminary results of a prospective single institution study. J Contemp Brachytherapy 2018; 10: 115-122.
6.
Guy GP, Machlin SR, Ekwueme DU et al. Prevalence and costs of skin cancer treatment in the U.S., 2002-2006 and 2007-2011. Am J Prev Med 2015; 48: 183-187.
7.
Delishaj D, Laliscia C, Manfredi B et al. Non-melanoma skin cancer treated with high-dose-rate brachytherapy and Valencia applicator in elderly patients: a retrospective case series. J Contemp Brachytherapy 2015; 7: 437-444.
8.
Tormo A, Celada F, Rodriguez S et al. Non-melanoma skin cancer treated with HDR Valencia applicator: clinical outcomes. J Contemp Brachytherapy 2014; 6: 167-172.
9.
Fronek LF, Dorton D. Surgical outcomes following Mohs micrographic surgery for basal cell carcinoma on the distal third of the nose. J Clin Aesthet Dermatol 2022; 15: 32-36.
10.
Leus AJG, Frie M, Haisma MS et al. Treatment of keratinocyte carcinoma in elderly patients – a review of the current literature. J Eur Acad Dermatol Venereol 2020; 34: 1932-1943.
11.
Garcovich S, Colloca G, Sollena P et al. Skin cancer epidemics in the elderly as an emerging issue in geriatric oncology. Aging Dis 2017; 8: 643-661.
12.
Lancellotta V, Kovács G, Tagliaferri L et al. The role of personalized interventional radiotherapy (brachytherapy) in the management of older patients with non-melanoma skin cancer. J Geriatr Oncol 2019; 10: 514-517.
13.
Guix B, Finestres F, Tello J et al. Treatment of skin carcinomas of the face by high-dose-rate brachytherapy and custom-made surface molds. Int J Radiat Oncol Biol Phys 2000; 47: 95-102.
14.
Taylor JM, Dasgeb B, Liem S et al. High-dose-rate brachytherapy for the treatment of basal and squamous cell carcinomas on sensitive areas of the face: a report of clinical outcomes and acute and subacute toxicities. Adv Radiat Oncol 2021; 6: 100616.
15.
Shah C, Ouhib Z, Kamrava M et al. The American Brachytherapy society consensus statement for skin brachytherapy. Brachytherapy 2020; 19: 415-426.
16.
Guinot JL, Rembielak A, Perez-Calatayud J et al. GEC-ESTRO ACROP recommendations in skin brachytherapy. Radiother Oncol 2018; 126: 377-385.
17.
Gonzalez-Perez V, Rembielak A, Guinot JL et al. H&N and Skin (HNS) GEC-ESTRO Working Group critical review of recommendations regarding prescription depth, bolus thickness and maximum dose in skin superficial brachytherapy with flaps and customized moulds. Radiother Oncol 2022; 175: 122-132.
18.
Jaberi R, Siavashpour Z, Akha NZ et al. Validation of an individualized home-made superficial brachytherapy mold applied for deep nonmelanoma skin cancer. Rep Pract Oncol Radiother 2022; 27: 1010-1018.
19.
Esmati E, Abyaneh R, Jaberi R et al. Surface mold brachytherapy for head and neck non-melanoma skin cancer - local control rates and survival: A retrospective analysis. J Contemp Brachytherapy 2024; 16: 323-334.
20.
Zaorsky NG, Lee CT, Zhang E et al. Hypofractionated radiation therapy for basal and squamous cell skin cancer: A meta-analysis. Radiother Oncol 2017; 125: 13-20.
21.
Chen T, Bertenthal D, Sahay A et al. Predictors of skin-related quality of life after treatment of cutaneous basal cell carcinoma and squamous cell carcinoma. Arch Dermatol 2007; 143: 1386-1392.
22.
Steenrod AW, Smyth EN, Bush EN et al. A qualitative comparison of symptoms and impact of varying stages of basal cell carcinoma. Dermatol Ther (Heidelb) 2015; 5: 183-199.
23.
Thompson AK, Kelley BF, Prokop LJ et al. Risk factors for cutaneous squamous cell carcinoma recurrence, metastasis, and disease-specific death: a systematic review and meta-analysis. JAMA Dermatol 2016; 152: 419-428.
24.
Chicheł A, Chyrek AJ, Kluska A et al. Advanced non-melanoma skin cancer in elderly patients: When surgery says NO, interventional radiotherapy (brachytherapy) says YES. J Contemp Brachytherapy 2023; 15: 235-244.
25.
Lee CD. Recent developments and best practice in brachytherapy treatment planning. Br J Radiol 2014; 87: 20140146.
26.
Poltorak M, Banatkiewicz P, Poltorak L et al. Brachytherapy and 3D printing for skin cancer: A review paper. J Contemp Brachytherapy 2024; 16: 156-169.
27.
Poltorak M, Banatkiewicz P, Poltorak L et al. Individualized 3D printing for skin cancer brachytherapy: Development, implementation, clinical applications, and treatment assessment. J Contemp Brachytherapy 2024; 16: 173-183.
